New COVID Booster Shot Authorized By FDA despite No Human Trials Done

If it wasn’t concerning enough that COVID shots were tested only for a short period of time before being pushed on the masses, a new COVID booster is ready to go despite no human trials.

The Food and Drug Administration (FDA) reportedly will release a new COVID-19 booster shot this week to target the Omicron variant. However, human trials are not set to be completed for several months, meaning only testing done on mice is being considered.

The new shot will be bivalent, meaning it can supposedly target both the original COVID variant as well as the Omicron strain.

Americans will most likely be able to access the shot even though it has yet to be tested on humans. Instead, the FDA thinks testing on mice is sufficient to gather COVID vaccine information and then give Americans access to the shots.

The Wall Street Journal wrote, “The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week without a staple of its normal decision-making process: data from a study showing whether the shots were safe and worked in humans.”

FDA Commissioner Robert Califf discussed emergency use and how the government agency plans to use that as a way to push through unvetted boosters.

“FDA will rely on the totality of the available evidence in making a decision, including: Clinical trial data from other bivalent mRNA COVID-19 boosters RWE from current COVID-19 vaccines administered to millions of people, non-clinical data for the bivalent BA.4/5 vaccines, bivalent and multivalent vaccines are very common and modifying a vaccine to include different virus strains often does not require a change in other ingredients,” Califf said on Twitter.

Moderna and Pfizer will manufacture the boosters, which both use the controversial mRNA component.

The inventor of the mRNA technology, Dr. Robert Malone, spent his career in pharmaceuticals and drug repurposing. He has spoken out about the mRNA component in COVID shots and warned that animals in his trials kept dying.

Califf continued to downplay the significance of the unvetted booster and said it was no different than authorizing the annual flu vaccine.

“Real world evidence from the current mRNA COVID-19 vaccines, which have been administered to millions of individuals, show us that the vaccines are safe,” Califf added. “As we know from prior experience, strain changes can be made without affecting safety.”

As more cases of heart issues, stroke, blood clots and autoimmune disorders continue to be diagnosed in COVID-vaccinated people, less testing appears to be irresponsible at best.